Return On Equity of Foghorn Therapeutics Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Foghorn Therapeutics Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Foghorn Therapeutics Inc. Return On Equity for the quarter ending 31 Dec 2025 was 88%, a 53% decline year-over-year.
  • Foghorn Therapeutics Inc. annual Return On Equity for 2025 was 88%, a 53% decline from 2024.
  • Foghorn Therapeutics Inc. annual Return On Equity for 2024 was 187%, a 1.1% decline from 2023.
  • Foghorn Therapeutics Inc. annual Return On Equity for 2023 was 189%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Foghorn Therapeutics Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 88% -98% -53% 01 Oct 2025 31 Dec 2025
Q3 2025 105% -62% -37% 01 Jul 2025 30 Sep 2025
Q2 2025 142% +1.8% +1.3% 01 Apr 2025 30 Jun 2025
Q1 2025 215% +83% +63% 01 Jan 2025 31 Mar 2025
Q4 2024 187% -2.2% -1.1% 01 Oct 2024 31 Dec 2024
Q3 2024 168% -147% -47% 01 Jul 2024 30 Sep 2024
Q2 2024 140% -786% -85% 01 Apr 2024 30 Jun 2024
Q1 2024 132% +1080% 01 Jan 2024 31 Mar 2024
Q4 2023 189% +490% 01 Oct 2023 31 Dec 2023
Q3 2023 315% +496% 01 Jul 2023 30 Sep 2023
Q2 2023 926% +1073% 01 Apr 2023 30 Jun 2023
Q1 2023 -947% -829% -698% 01 Jan 2023 31 Mar 2023
Q4 2022 -301% -202% -203% 01 Oct 2022 31 Dec 2022
Q3 2022 -181% -100% -122% 01 Jul 2022 30 Sep 2022
Q2 2022 -147% -6.2% -4.4% 01 Apr 2022 30 Jun 2022
Q1 2022 -119% +1321% +92% 01 Jan 2022 31 Mar 2022
Q4 2021 -100% -234% -174% 01 Oct 2021 31 Dec 2021
Q3 2021 -81% 01 Jul 2021 30 Sep 2021
Q2 2021 -141% 01 Apr 2021 30 Jun 2021
Q1 2021 -1440% 01 Jan 2021 31 Mar 2021
Q4 2020 134% 01 Oct 2020 31 Dec 2020

Foghorn Therapeutics Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 88% -98% -53% 01 Jan 2025 31 Dec 2025
2024 187% -2.2% -1.1% 01 Jan 2024 31 Dec 2024
2023 189% +490% 01 Jan 2023 31 Dec 2023
2022 -301% -202% -203% 01 Jan 2022 31 Dec 2022
2021 -100% -234% -174% 01 Jan 2021 31 Dec 2021
2020 134% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.